GNA Biosolutions
Entry
2019
Hold
7yr
Status
Active
Who owns GNA Biosolutions?
GNA Biosolutions is currently owned by Bayern Kapital through Seedfonds Bayern (1996 vintage), since 2019. Across its history, GNA Biosolutions has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-08-10
Most recent investor
Bayern KapitalSeedfonds Bayern · 1996 · VC
3 ownership periods · full history below
Key facts
HQGermany
SectorMedTech
StatusAcquired
Key takeaways
- ·Held by Bayern Kapital since 2019 (7Y hold).
- ·Average hold across 2 realized cycles: 6 years.
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2015 · present
Unternehmertum Venture Capital PartnersExited 2021
2015 · 2021(6yr) · UVC Fund I · 2011 · VC
Trade Sale · to
MOIC
–
Bayern KapitalActive
2019 · present(7yr) · Seedfonds Bayern · 1996 · VC
More from Seedfonds Bayern
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Optos
Exited 2015
Amadeus Capital Partners
UK
to
Axomove
Active
Go Capital
France· 2026
Bioliberty
Active
Scottish National Investment Bank
UK· 2026
CertHub
Active
Cusp Capital Partners
Germany· 2026
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)
Switzerland· 2026
CollimateHealth
Active
Caesar Ventures Management
Germany· 2026
Track GNA Biosolutions
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on GNA Biosolutions.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue